ロード中…
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
The nucleic acid polymer REP 2139 inhibits assembly/secretion of hepatitis B virus (HBV) subviral particles. Previously, REP 2139‐Ca and pegylated interferon (pegIFN) in HBV/hepatitis delta virus (HDV) coinfection achieved high rates of HDV RNA and hepatitis B surface antigen (HBsAg) loss/seroconver...
主要な著者: | , , , , , , , , , , , , , |
---|---|
フォーマット: | Online 論文 テキスト |
言語: | English |
出版事項: |
John Wiley and Sons Inc.
2020
|
主題: | |
オンライン・アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850315/ https://www.ncbi.nlm.nih.gov/pubmed/33553968 http://dx.doi.org/10.1002/hep4.1633 |